Musculoskeletal Oncology

Musculoskeletal and Orthopaedic Oncology Disease Management Group (DMG) at Metro Cancer Institute comprises of a group of experts who are focused on providing an all-encompassing treatment for patients with benign or malignant tumors of bone as well as soft tissue. It is now proven that multidisciplinary involvement is vital to ensure the best outcome in the treatment of these rare illnesses as we, in the Metro Cancer Institute boast of a group of highly experienced specialists in the treatment of patients suffering from soft tissue and bone tumors. The team is comprised of orthopedic, surgical medical, as well as radiation oncologists as well as pathologists, radiologists onco-psychologists, physiotherapists, nuclear medicine specialists, and molecular cancerologists.

The treatment of every Musculoskeletal cancer patient requires individualized treatment and personalization. The Metro Cancer Institute is the place to go. Metro Cancer Institute, all of these cases are reviewed on a multidisciplinary Tumour board which is where experts from the fields of orthopaedic and radiation oncology, surgical surgery and radiology, medical oncology and pathology debate every case in detail and devise an approach to treatment that will not only increase the chances of survival, but also provides excellent functional results.